Continuous renal replacement therapy: Current practice in Australian and New Zealand intensive care units

Critical Care and Resuscitation

Volumn 17, Issue 2, 2015, Pages 83-91

  Fealy, Nigel ^a,b,c   Aitken, Leanne ^b,d,e   Du Toit, Eugene ^d   Baldwin, Ian ^a,c,f  

^a AUSTIN HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d GRIFFITH UNIVERSITY   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AUSTRALIA; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; COMPLICATION; HEALTH CARE SURVEY; HUMAN; INTENSIVE CARE; PATIENT SELECTION; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY;

ANTICOAGULANTS; AUSTRALIA; HEALTH CARE SURVEYS; HUMANS; INTENSIVE CARE; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; RENAL INSUFFICIENCY; RENAL REPLACEMENT THERAPY; VASCULAR ACCESS DEVICES;

EID: 84930242254     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 1 Uchino S, Bellomo R, Morimatsu H, et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Continuous renal replacement therapy: a worldwide practice survey. Intensive Care Med 2007; 33: 1563-70.
2. 2 Vanholder R, Van Biesen W, Lameire N. What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol 2001; 12: S40-43.
3. 3 Ronco C, Cruz D, Bellomo R. Continuous renal replacement therapy in critical illness. Contrib Nephrol 2007; 156: 309-19.
4. 4 Joannidis M, Forni LG. Clinical review: Timing of renal replacement therapy. Crit Care 2011; 15: 223.
5. 5 Ostermann M, Chang RW. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007; 35: 1837-43.
6. 6 Uchino S, Kellum JA, Bellomo R, et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational multicentre study. JAMA 2005; 294: 813-8.
7. 7 Dennen P, Douglas IS, Anderson R. Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med 2010; 38: 261-75.
8. 8 Bellomo R, Cass A, Cole L, et al; RENAL Replacement Therapy Study Investigators. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-38.
9. 9 VA/NIH Acute Renal Failure Trial Network; Palevsky PM, Zhang JH, O’Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20.
10. 10 RENAL Study Investigators. Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. Crit Care Resusc 2008; 10: 225-30.
11. 11 Overberger P, Pesacreta M, Palevsky PM; VA/NIH Acute Renal Failure Trial Network. Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices. Clin J Am Soc Nephrol 2007; 2: 623-30.
12. 12 Legrand M, Darmon M, Joannidis M, Payen D. Management of renal replacement therapy in ICU patients: an international survey. Intensive Care Med 2013; 39: 101-8.
13. 13 Jones S, Devonald MA. How acute kidney injury is investigated and managed in UK intensive care units – a survey of current practice. Nephrol Dial Transplant 2013; 28: 1186-90.
14. College of Intensive Care Medicine of Australia and New Zealand. Minimum Standards for Intensive Care Units, IC-1, 2011. http://www.cicm.org.au/CICM_Media/CICMSite/CICM-Website/Resources/Professional%20Documents/IC-1-Minimum-Standardsfor-Intensive-Care-Units.pdf (accessed Dec 2014).
15. 15 Silvester W, Bellomo R, Cole L. Epidemiology, management and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 2001; 29: 1910-5.
16. 16 Ricci Z, Ronco C, D’Amico G, et al. Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant 2006; 21: 690-6.
17. 17 Uchino S, Fealy N, Baldwin I, et al. Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 2003; 94: c94-8.
18. 18 Uchino S, Toki N, Takeda K, et al; Japanese Society for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group. Validity of low-intensity continuous renal replacement therapy. Crit Care Med 2013; 41: 2584-91.
19. 19 Dunn WJ, Sriram S. Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables. Crit Care Resusc 2014; 16: 225-31.
20. 20 Schetz M. Vascular access for IHD and CRRT. Contrib Nephrol 2007; 156: 275-86.
21. 21 Wentling AG. Hemodialysis catheters: materials, design and manufacturing. Contrib Nephrol 2004; 142: 112-27.
22. 22 Vanholder R: Vascular access: care and monitoring of function. Nephrol Dial Transplant 2001; 16: 1542-5.
23. 23 Fealy N, Kim I, Baldwin I, et al. A comparison of the Niagara and Medcomp catheters for continuous renal replacement therapy. Ren Fail 2013; 35: 308-13.
24. 24 Kim I, Fealy N, Baldwin I, Bellomo R. A comparison of the Niagara and Dolphin catheters for continuous renal replacement therapy. Int J Artif Organs 2011; 34: 1061-6.
25. 25 Kim IB, Fealy N, Baldwin I, Bellomo R. Insertion side, body position and circuit life during continuous renal replacement therapy with femoral vein access. Blood Purif 2011; 31: 42-6.
26. 26 Meier P, Meier R, Turini P, et al. Prolonged catheter survival in patients with acute kidney injury on continuous renal replacement therapy using a less thrombogenic micropatterned polymer modification. Nephrol Dial Transplant 2011; 26: 628-35.
27. 27 Parienti JJ, Thirion M, Mégarbane B, et al; Members of the Cathedia Study Group. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008; 299: 2413-22.
28. 28 Parienti JJ, Mégarbane B, Fischer MO, et al; Cathedia Study Group. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med 2010; 38: 1118-25.
29. 29 Naka T, Egi M, Bellomo R, et al. Resistance of vascular access catheters for continuous renal replacement therapy: an ex vivo evaluation. Int J Artif Organs 2008; 31: 905-9.
30. 30 Dugué AE, Levesque SP, Fischer MO, et al. Vascular access sites for acute renal replacement in intensive care units. Clin J Am Soc Nephrol 2012; 7: 70-7.
31. 31 Canaud B. Haemodialysis catheter-related infection: time for action. Nephrol Dial Transplant 1999; 14: 2288-90.
32. 32 Davenport A, Mehta R. The Acute Dialysis Quality Initiative (ADQI) – part VI: access and anticoagulation in CRRT. Adv Ren Replace Ther 2002; 9: 273-81.
33. 33 KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012; 2: 1-138.
34. 34 Monchi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin for anticoagulation in continuous venovenous haemofiltration: a prospective randomized study. Intensive Care Med 2004; 30: 260-5.
35. 35 Tovey L, Dickie H, Gangi S, et al. Beyond the randomized clinical trial: citrate for continuous renal replacement therapy in clinical practice. Nephron Clin Pract 2013; 124: 119-23.
36. 36 Lanckhor C, Hahnenkamp K, Boschin M. Continuous renal replacement therapy with regional citrate anticoagulation: do we really know the details? Curr Opin Anaesthesiol 2013; 26: 428-37.
37. 37 Oudemans-van Straaten HM, Ostermann M. Bench-to-bedside review: citrate for continuous renal replacement therapy, from science to practice. Crit Care 2012; 16: 249.
38. 38 Tolwani A, Wille KM. Advances in continuous renal replacement therapy: citrate anticoagulation update. Blood Purif 2012; 34: 88-93.